Infectio.ro 12

infecţio
ro
sinteze
Bibliografie
17. CDC (Centers for disease control and prevention). Recom- 135-140.
mendations for preventing transmission of infections among 32. Noiri E., Nakao A., Oya A., Fujita T., Kimura S. Hepatitis C
chronic hemodialysis patients. MMWR Recomm Rep 2001, 50 virus in blood and dialysate in hemodialysis. Am J Kidney Dis
(RR-5): 1-43. 2001, 37: 38-42.
18. De Lamballerie X., Olmer M., Bouchouareb D., Zandotti C., 33. Sampietro M., Badalamenti S., Salvadori S. et al. High preva-
De Micco P. Nosocomial transmission of hepatitis C virus in lence of a rare hepatitis C virus in patients treated in the same
haemodialysis patients. J Med Virol 1996, 49: 296-302. hemodialysis unit: evidence for nosocomial transmission of
19. Caramelo C., Bartolome J., Albalate M. et al. Undiagnosed HCV. Kidney Int 1995, 47: 911-7.
hepatitis C virus infection in hemodialysis patients : value of 34. Lombardi M., Cerrai T., Geatti S. et al. Results of a national
HCV RNA and liver enzyme levels. Kidney Int 1996, 50: 2.027- epidemiological investigation on HCV infection among dialy-
2.031. sis patients. (Survey by the Italian Branch of EDTNA/ERCA). J
20. Iwasaki Y., Esumi M., Hosokawa N., Yanai M., Kawano K. Oc- Nephrol 1999, 12: 322-7.
casional infection of hepatitis C virus occurring in haemodi- 35. Alfurayh O., Sabeel A., Al Ahdal M.N. et al. Hand contami-
alysis units identified by serial monitoring of the virus infec- nation with hepatitis C virus in staff looking after hepatitis
tion. J Hosp Infect 2000, 45: 54-61. C-positive hemodialysis patients. Am J Nephrol 2000, 20:
21. Pujol F.H., Ponce J.G., Lema M.G. et coll. High incidence of 103-6.
hepatitis C virus infection in hemodialysis patients in units 36. Okuda K., Hayashi H., Yokozeki K. et al. Acute hepatitis C
with high prevalence. J Clin Microbiol 1996, 34 : 1.633-6. among renal failure patients on chronic haemodialysis. J Gas-
22. Forns X., Fernandez-Llama P., Pons M. et al. Incidence and troenterol Hepatol 1998, 13: 62-67 .
risk factors of hepatitis C virus infection in a haemodialysis 37. Nakayama E., Akiba T., Marumo F., Sato C. Prognosis of anti-
unit. Nephrol Dial Transplant 1997, 12: 736-740. hepatitis C virus antibody-positive patients on regular hemo-
23. Simon N., Courouce A.M., Lemarrec N., Trepo C., Ducamp S. dialysis therapy. J Am Soc Nephrol 2000, 11: 1.896-1.902.
A twelve year natural history of hepatitis C virus infection in 38. Allain J.P., Dong Y., Vandamme A.M., Moulton V., Salemi M.
hemodialyzed patients. Kidney Int 1994, 46: 504-511. Evolutionary rate and genetic drift of hepatitis C virus are not
24. Vlăduţiu D.S., Coşa A., Neamţu A. et al. Infections with hepa- correlated with the host immune response: studies of infected
titis B and C viruses in patients on maintenance dialysis in donor-recipient clusters. J Virol 2000, 74 : 2.541-2.549.
Romania and in former communist countries : yellow spots on 39. Arenas Jimenez M.D., Sanchez-Paya J., Arenas Jimenez D.
a blank map ? J Viral Hepat 2000, 7: 313-9. Standard precautions in haemodialysis - the gap between the-
25. Kobayashi M., Tanaka E., Oguchi H. et al. Prospective fol- ory and practice. Nephrol Dial Transplant 1999, 14: 823-825.
low-up study of hepatitis C virus infection in patients un- 40. Simmonds P. Viral heterogeneity of the hepatitis C virus. J
dergoing maintenance haemodialysis: comparison among Hepatol 1999, 31: 54-60.
haemodialysis units. J Gastroenterol Hepatol 1998, 13: 604- 41. Izopet J., Rostaing L., Moussion F. et al. High rate of hepatitis
609. C virus clearance in hemodialysis patients after interferon-al-
26. Izopet J., Pasquier C., Sandres K., Puel J., Rostaing L. Molecu- pha therapy. J Infect Dis 1997, 176: 1.614-7.
lar evidence for nosocomial transmission of hepatitis C virus 42. Izopet J., Sandres-Saune K., Salama G. et al. Infections noso-
in a French hemodialysis unit. J Med Virol 1999, 58: 139-144. comiales à HCV en hémodialyse. Annales de Biologie Clinique
27. Dos Santos J.P., Loureiro A., Cendoroglo Neto M., Pereira B.J. 2001, 59: 7-8.
Impact of dialysis room and reuse strategies on the incidence 43. Zeldis J.B., Depner T.A., Kuramoto I.K. et al. The prevalence
of hepatitis C virus infection in haemodialysis units. Nephrol of hepatitis C virus antibodies among hemodialysis patients.
Dial Transplant 1996, 11: 2.017-2.022. Ann Intern Med 1990, 112: 958-960.
28. Espinosa M., Martin-Malo A., Alvarez de Lara M.A., Soriano 44. EUROPEAN RENAL ASSOCIATION. European best practice
S., Aljama P. High ALT levels predict viremia in anti-HCV-posi- guidelines for haemodialysis (Part 1). Section VI. Haemodialy-
tive HD patients if a modified normal range of ALT is applied. sis-associated infection. VI.6 Prevention and mangement of
Clin Nephrol 2000, 54: 151-6. HBV, HCV and HIV in HD patients. Nephrol Dial Transplant
29. Chan T.M., Lok A.S., Cheng I.K. Hepatitis C infection 2002, 17 (Suppl. 7): 78-81.
among dialysis patients: a comparison between patients 45. Saab S., Brezina M., Gitnick G., Martin P., Yee H.F. Jr. Hepati-
on maintenance haemodialysis and continuous ambula- tis C screening strategies in hemodialysis patients. Am J Kid-
tor y peritoneal dialysis. Nephrol Dial Transplant 1991, ney Dis 2001, 38: 91-97.
6: 944-947. 46. Rampino T., Arbustini E., Gregorini M. et al. Hemodialysis
30. Delarocque-Astagneau E., Baffoy N., Thiers V. et al. Outbreak prevents liver disease caused by hepatitis C virus: role of hepa-
of hepatitis C virus infection in a hemodialysis unit: potential tocyte growth factor. Kidney Int 1999, 56: 2286-2291
transmission by the hemodialysis machine ? Infect Control 47. Department of Health (London). Good practice guidelines
Hosp Epidemiol 2002, 23: 328-334. for renal dialysis/transplantation units. Prevention and con-
31. Irish D.N., Blake C., Christophers J. et al. Identification of trol of blood-borne viruses infection. 2002: 72 p.
hepatitis C virus seroconversion resulting from nosocomial 48. Gilli P., Soffritti S., De Paoli Vitali E., Bedani P.L. Preven-
transmission on a haemodialysis unit: implications for infec- tion of hepatitis C virus in dialysis units. Nephron 1995,
tion control and laboratory screening. J Med Virol 1999, 59: 70: 301-306.
pag. 36
nr. 4/decembrie 2007
Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 | Page 47 | Page 48 | Page 49 | Page 50 | Page 51 | Page 52 | Page 53 | Page 54 | Page 55 | Page 56 | Page 57 | Page 58 | Page 59 | Page 60 | Page 61 | Page 62 | Page 63 | Page 64 | Page 65 | Page 66 | Page 67 | Page 68